Synchrony Financial, along with its subsidiaries, functions as a notable consumer financial services provider in the United States. The company specializes in offering a diverse range of credit products, which include credit cards, commercial credit products, and consumer installment loans. Its offerings extend to private label credit cards, dual cards, co-branded and general-purpose credit cards, as well as short- and long-term installment loans, and various consumer banking products. Additionally, the company provides deposit solutions such as certificates of deposit, individual retirement accounts, money market accounts, and savings accounts tailored for both retail and commercial clients, accepting deposits via third-party securities brokerage firms. Synchrony Financial also features debt cancellation products for its credit card clients, accessible through online platforms, mobile applications, and direct mail. Furthermore, it delivers healthcare payment and financing solutions branded under CareCredit, Pets Best, and Walgreens. The company actively engages in financing solutions within the apparel, specialty retail, outdoor, music, and luxury sectors, while also supporting point-of-sale consumer financing for audiology and dental services. These credit products are made available through partnerships with a variety of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare providers. Its deposit products are offered through multiple channels, including both digital and print media. Synchrony Financial serves a wide range of industries, encompassing digital, health and wellness, retail, home, auto, powersports, jewelry, pets, among others. The weighted average number of diluted shares outstanding is 357,843,000.00 reflecting potential dilution effects. The operating income ratio is 0.24 indicating the company's operational profitability margin. The company achieved a significant net income of $3,552,000,000.00 showcasing its strong financial health. EBITDA is $5,135,000,000.00 a key indicator of the company's operational profitability, while gross profit stands at $9,756,000,000.00 highlighting the company's profitability from core operations. In terms of market positioning, Synchrony Financial's stock is reasonably priced at $76.59 appealing to a broad range of investors. The stock has a high average trading volume of 4,456,249.00 indicating strong liquidity which supports investor confidence. With a mid-range market capitalization of $23,594,809,220.00 the company is recognized as a steady performer in the financial services sector. It is a key player in the consumer financial services industry, contributing significantly to the overall market landscape. Moreover, it belongs to the Financial Services sector, driving innovation and growth while continually adapting to the evolving needs of consumers and businesses alike.